NOTCH3產(chǎn)品信息
英文名稱(chēng):Neurogenic locus notch homolog protein 3
中文名稱(chēng):神經(jīng)源性基因座notch同源蛋白-3
靶點(diǎn)別稱(chēng):NOTCH3
物種:Human
標(biāo)簽:Fc Tag
屬性:Protein
標(biāo)記:Unconjugated
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human NOTCH3, Fc Tag (NO3-H5255) is expressed from human 293 cells (HEK293). It contains AA Ala 40 - Glu 467 (Accession # Q9UM47-1).
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a human IgG1 Fc tag at the C-terminus
The protein has a calculated MW of 71.4 kDa. The protein migrates as 65-75 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 25 mM Arginine, 150 mM NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
Notch3是四種哺乳動(dòng)物Notch蛋白之一,作為信號(hào)受體,參與發(fā)育模式、細(xì)胞命運(yùn)決定、細(xì)胞存活和增殖的調(diào)節(jié)。Notch3可以與膜結(jié)合配體Jagged1、Jagged2和Delta1相互作用,調(diào)節(jié)細(xì)胞命運(yùn)的決定。通過(guò)配體激活,缺口細(xì)胞內(nèi)結(jié)構(gòu)域(NICD)被釋放并形成轉(zhuǎn)錄激活子RBPJ/RBPSHH復(fù)合物,激活分裂位點(diǎn)增強(qiáng)子的基因。因此,Notch3的激活可以導(dǎo)致分化、增殖和凋亡程序的實(shí)施。
關(guān)鍵字: NOTCH3;NOTCH3蛋白;NOTCH3重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶(hù)超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。